Fresenius | FRE - Assets


Fresenius reported EUR41.84B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Akzo Nobel EUR 16.02B 114M Sep/2026
Alcon AG USD 31.1B 521M Jun/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
BASF EUR 83.87B 2.1B Jun/2026
Bayer EUR 107.29B 659M Jun/2026
Beiersdorf EUR 13.32B 560M Jun/2026
DaVita Healthcare Partners USD 17.71B 210.12M Jun/2026
Demant DKK 40.03B 951M Jun/2026
E.ON EUR 115.44B 1.78B Jun/2026
Essilor EUR 65.06B 1.16B Jun/2026
Fresenius EUR 41.84B 526M Jun/2026
Fresenius Medical Care EUR 31.29B 174.35M Jun/2026
Getinge SEK 57.37B 6.55B Jun/2026
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GN Store Nord DKK 29.55B 996M Jun/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 52.69B 383M Jun/2026
Novartis USD 122.03B 3.5B Jun/2026
Philips EUR 26.7B 565M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
RWE EUR 115.73B 1.04B Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Smith & Nephew USD 11.01B 321M Jun/2026